The National Institute of Genomic Medicine (Inmegen) south of Mexico City, offers a service to find out if there is a hereditary genetic load of ovarian or breast cancer in women.
As in the case of Alexa, who has relatives who suffered from this cancer, So he went to have the study done.
“Within my family were the three generations, they presented approximately six cases of cancer. My risk of developing this type of cancer is less than 1%.
Alexa Illescas, patient
These results were obtained thanks to the Inmegen Early Surveillance Strategyfor women with family members who had breast or ovarian cancer.
“It is initially intended for all women 18 years of age and older and depending on their results, it is who we are going to study later.”
Ronny Kershenovich Sefchovich, in charge of Inmegen’s Early Surveillance Strategy
The first consultation is an interview about family history, if the case warrants it, then, A DNA study is performed, all at no cost.
“It is calculated if they are candidates or not to have the DNA test done and Let’s analyze the more than 12 genes that exist for hereditary breast and ovarian cancerHowever, that does not mean that they are born with cancersimply we are born with a greater predisposition others to develop”.
Ronny Kershenovich Sefchovich, in charge of Inmegen’s Early Surveillance Strategy
At the same time, there psychological and nutritional care,
“If any patient who already brings the cancer tendency, and he loses weight, we would leave him at his ideal weight, that decreases the percentage of incidence by 30%”.
Jorge Alberto Azar Dick, bariatric doctor at Inmegen
To request the genetic study, you must register on the page:
To obtain a consultation you can dial the number:
55-53-50-19-00 at extension 1112 from 8 in the morning to 2 in the afternoon from Monday to Friday
There is also virtual care for women from other entities.
“I repeat it, all cancer is curable if detected early weather and there is nothing better than having tangible information, ready for us to make decisions”.
Ronny Kershenovich Sefchovich, in charge of Inmegen’s Early Surveillance Strategy
–
